Drugs

Lurasidone : Therapeutic uses, Dosage & Side Effects

Lurasidone : Therapeutic uses, Dosage & Side Effects

Lurasidone is a second-generation atypical antipsychotic drug, can be used in treating schizophrenia, depression associated with bipolar disorder. It may also be used for other conditions as determined by your doctor.
Dose : 20-120 mg
Route : Oral
Plasma Half-life : 18 hours
Duration of action : Long
Bioavailability : 9–19% (oral)
Chemical formula : C28H36N4O2S
IUPAC name : (3aR,4S,7R,7aS)-2-{(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-ylmethyl] cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione
Trade name : Latuda
Therapeutic uses :  Lurasidone has following usage :

  • Primarily indicated as anti-psychotic drug for treating psychoses particularly Schizophrenia (generally first-line therapy).
  • Indicated for the treatment of bipolar depression.
  • Can be used as tranquilizers to manage agitated and disruptive behavior secondary to other disorders.

Side effects :  Adverse effects of the Lurasidone can occur in practically all patients and are significant in about 80% ; Lurasidone may produce following side effects:

  • CNS ailments like Sedation, drowsiness, lethargy, mental confusion, increased appetite, weight gain, aggravation of seizures
  • CVS effects including Postural (orthostatic) hypotension, palpitation, inhibition of ejaculation
  • Anticholinergic effects such as Dry mouth, blurring of vision, constipation, urinary incontinence
  • Nausea, Vomiting,
  • Rarely Hyperprolactinemia – amenorrhoea, infertility, galactorrhoea and gynaecomastia
  • Rarely Extrapyramidal disturbances (extrapyramidal symptoms EPS) such as Parkinsonism, Acute muscular dystonias, Akathisia, Malignant neuroleptic syndrome, Tardive dyskinesia

Contraindications :

  • It should be used cautiously in patients with seizure disorders (since it may lower the seizure threshold)or those with an increased risk for seizures, such as withdrawal from alcohol.
  • Lurasidone is contraindicated in individuals who are taking strong CYP3A4 inhibitors (ketoconazole, clarithromycin, ritonavir, levodropropizine, etc.) or inducers (carbamazepine, St. John’s wort, phenytoin, rifampicin etc.).
  • The use of lurasidone in pregnant women has not been studied and is not recommended, although it should be noted that it is a category B drug.Excretion in breast milk is also unknown; lurasidone is not recommended for breastfeeding women.
  • In the United States it is not indicated for use in children.

For detailed query or in case of uncertainty, Always consult your doctor or pharmacist.

Doctoralerts is dedicated to empower every person with the knowledge of medical health by providing precise, credible & valuable health information to better manage their own health status & thereby, improvement in health status of community.

Categories

Copyright © 2020 All Rights Reserved | DoctorAlerts does not provide medical advice, diagnosis or treatment.

To Top